CN102302764A - Traditional Chinese medicine composition used for treating gastric disease - Google Patents

Traditional Chinese medicine composition used for treating gastric disease Download PDF

Info

Publication number
CN102302764A
CN102302764A CN2011102771039A CN201110277103A CN102302764A CN 102302764 A CN102302764 A CN 102302764A CN 2011102771039 A CN2011102771039 A CN 2011102771039A CN 201110277103 A CN201110277103 A CN 201110277103A CN 102302764 A CN102302764 A CN 102302764A
Authority
CN
China
Prior art keywords
parts
rhizoma
chinese medicine
medicine composition
mel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2011102771039A
Other languages
Chinese (zh)
Other versions
CN102302764B (en
Inventor
石启明
石玲玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2011102771039A priority Critical patent/CN102302764B/en
Publication of CN102302764A publication Critical patent/CN102302764A/en
Application granted granted Critical
Publication of CN102302764B publication Critical patent/CN102302764B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition used for treating gastric disease. The traditional Chinese medicine is prepared from raw materials of, by weight: 9 to 13 parts of submature bitter orange, 15 to 22 parts of largehead atractylodes rhizome, 14 to 16 parts of pinellia, 16 to 24 parts of creeping liriope, 12 to 22 parts of common ginger root, and 30 to 60 parts of honey. The traditional Chinese medicine composition provided by the invention is advantaged in short treatment course, fast effect, low raw medicine price, and no obvious side-effect.

Description

The Chinese medicine composition of treatment gastropathy
Technical field
The present invention relates to the field of Chinese medicines, particularly relate to a kind of Chinese medicine composition of treating gastropathy.
Background technology
Stomach is one of most important digestive organs of human body; Disease of stomach has similar symptom; Uncomfortable like upper abdomen gastral cavilty portion; Pain; Glutted after meal; Acid regurgitation; Even feel sick; Vomiting or the like; Common clinically gastropathy has acute gastritis; Chronic gastritis; Gastric ulcer; Duodenal ulcer; Gastroduodenal complex ulcer etc.; Gastropathy often occurs in 40-50 between year; The male is more than the women; In the Chinese patent data base; The Chinese medicine patent of invention that many treatment gastropathy have been arranged is like No. 96100792.3 " a kind of Chinese medicine composition of treating gastropathy "; Number 98113807.1 " a kind of Chinese medicine of treating gastrointestinal disease " etc.The Chinese medicine preparation of above-mentioned all treatment disease of stomach has nothing in common with each other, and therapeutic effect also is not quite similar, so people continue to excavate Chinese material medicine resource, develops more efficiently medicine.
Summary of the invention
The present invention seeks to make the patient can remove the puzzlement of gastropathy fast, and have no side effect, not repeatedly for a kind of Chinese medicine composition of treating gastropathy is provided.
In order to achieve the above object; Technical scheme provided by the present invention is: a kind of Chinese medicine composition of treating gastropathy, it comprises following weight portion raw material: Fructus Aurantii 9-13 part, Rhizoma Atractylodis Macrocephalae 15-22 part, Rhizoma Pinelliae 14-16 part, Radix Ophiopogonis 16-24 part, Rhizoma Zingiberis Recens 12-22 part, Mel 30-60 part.
One embodiment of the present invention, it comprises following weight portion raw material: Fructus Aurantii 8-12 part, Rhizoma Atractylodis Macrocephalae 16-20 part, Rhizoma Pinelliae 14-16 part, Radix Ophiopogonis 16-20 part, Rhizoma Zingiberis Recens 14-22 part, Mel 30-60 part.
Another embodiment of the invention, it comprises following weight portion raw material: 8 parts of Fructus Aurantiis, 16 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of the Rhizoma Pinelliaes, 15 parts of Radix Ophiopogonis, 14 parts in Rhizoma Zingiberis Recens, 30 parts of Mel.
Another embodiment of the present invention, it comprises following weight portion raw material: 8 parts of Fructus Aurantiis, 16 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of the Rhizoma Pinelliaes, 16 parts of Radix Ophiopogonis, 14 parts in Rhizoma Zingiberis Recens, 30 parts of Mel.
The further embodiment of the present invention, it comprises following weight portion raw material: 10 parts of Fructus Aurantiis, 18 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of the Rhizoma Pinelliaes, 18 parts of Radix Ophiopogonis, 16 parts in Rhizoma Zingiberis Recens, 40 parts of Mel.
The further embodiment of the present invention, it comprises following weight portion raw material: 10 parts of Fructus Aurantiis, 20 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of the Rhizoma Pinelliaes, 20 parts of Radix Ophiopogonis, 18 parts in Rhizoma Zingiberis Recens, 50 parts of Mel.
The further embodiment of the present invention, it comprises following weight portion raw material: 11 parts of Fructus Aurantiis, 19 parts of the Rhizoma Atractylodis Macrocephalaes, 14 parts of the Rhizoma Pinelliaes, 17 parts of Radix Ophiopogonis, 18 parts in Rhizoma Zingiberis Recens, 30 parts of Mel.
The further embodiment of the present invention, it comprises following weight portion raw material: 12 parts of Fructus Aurantiis, 19 parts of the Rhizoma Atractylodis Macrocephalaes, 16 parts of the Rhizoma Pinelliaes, 16 parts of Radix Ophiopogonis, 20 parts in Rhizoma Zingiberis Recens, 60 parts of Mel.
The further embodiment of the present invention, it comprises following weight portion raw material: 9 parts of Fructus Aurantiis, 19 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of the Rhizoma Pinelliaes, 19 parts of Radix Ophiopogonis, 22 parts in Rhizoma Zingiberis Recens, 60 parts of Mel.
Adopt technique scheme, technique effect of the present invention has: the present invention treats short treating period, instant effect, and each crude drug is cheap, non-evident effect.
The specific embodiment
The characteristics and the function of each component of the present invention are following:
Fructus Aurantii, bitter, hot, sour, tepor is returned spleen, stomach, large intestine channel, the dispelling the stagnated QI removing food stagnancy reduces phlegm, and the painful abdominal mass that disappears ascending up spleen-Qi and Yang is controlled gastrointestinal retention, the feeling of fullness chest pain, constipation, heavy behind the dysentery, stagnate vapour lock, the thoracic obstruction, blocked-up chest, dyspepsia gastroenteritis.
The Rhizoma Atractylodis Macrocephalae, sweet, bitter, warm, return spleen, stomach warp, the spleen reinforcing stomach reinforcing, dampness with in, control deficient QI of the spleen and stomach, anorexia, fatigue and weakness, the deficiency-distension phlegm retention of having loose bowels, arthralgia chiefly caused by damp pathogen, dysuria, dizzy autonomous, nausea is uneasy.
The Rhizoma Pinelliae, hot, temperature, poisonous is returned spleen, stomach, lung meridian, drying dampness to eliminate phlegm, the stopping nausea and vomiting by lowering the adverse flow of QI dissolving lump and resolving mass is with controlling damp-phlegm, cold-phlegm, cough, the contrary vomiting of various stomaches, epigastric fullness, cough with asthma abundant expectoration, chest and diaphragm distension.
Sweet, little hardship, be slightly cold Radix Ophiopogonis, GUIXIN, lung, stomach warp, and nourishing YIN and moistening the lung, nourishing the stomach to promote the production of body fluid, the relieving restlessness that clears away heart-fire, lung dry cough, deficiency of YIN phthisical cough, Tianjin wound is thirsty, and it is vexed to quench one's thirst, insomnia, intestinal constipation.
Rhizoma Zingiberis Recens, hot, tepor are returned lung, spleen, stomach warp, deliver cold expelling, the stomach warming preventing or arresting vomiting, warming the lung to relieve cough is controlled anemofrigid cold, and the contrary vomiting of stomach has antipyretic-antalgic, stimulates gastric secretion, increases gastrointestinal peristalsis, the effect of protection gastric mucosa.
Mel, sweet, put down, return spleen, stomach, lung, large intestine channel, invigorating the spleen and replenishing QI, relieving spasm to stop pain, lung moistening, the cough-relieving loosening bowel to relieve constipation is controlled weakness of the spleen and stomach, and asthenia is eaten less, deficiency and coldness property epigastric pain, the xeropulmonary cough, chronic cough of deficiency lung, gastroduodenal ulcer is controlled in the dryness of the intestine constipation.
Pharmacology analysis of the present invention:
Control to dredge and regulate the flow of vital energy, clearing heat and expelling damp, the medicine of the spleen reinforcing of being good for the stomach, ancient prescription stomach medicine Fructus Aurantii, the Rhizoma Atractylodis Macrocephalae are " monarch " medicine, Fructus Aurantii dampness, dispelling the stagnated QI, removing food stagnancy reduces phlegm, the numbness that disappears, it is stagnant that ascending up spleen-Qi and Yang is controlled stomach, feeling of fullness, distending pain, expectorant ends the vapour lock gastroenteritis; The Rhizoma Atractylodis Macrocephalae can wet the spleen reinforcing of being good for the stomach by diuretic.The Rhizoma Pinelliae, Radix Ophiopogonis are " minister " medicine, the Rhizoma Pinelliae, drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, eliminating stagnation damp eliminating expectorant; Radix Ophiopogonis, nourishing YIN and moistening the lung, nourishing the stomach to promote the production of body fluid are played the medicine that share altogether, the effect that complements each other.Rhizoma Zingiberis Recens is " making " medicine, warming stomach for dispelling cold, aid digestion preventing or arresting vomiting.Mel is " assistant " medicine, invigorating the spleen and replenishing QI, and nourishing the lung to arrest cough, loosening bowel to relieve constipation is controlled a little less than the deficiency of the lung, and asthenia is eaten less.Control the stomach patient, contemporary well-known doctor " Zhu Jinzhong argumentation ", the full vomiter of flatulence, impairing the spleen and stomach, spleen deficiency generating phlegm hinders in the phlegm retention, and causes abnormal ascending-descending of QI, does not heal so tell for a long time, and the big Rhizoma Pinelliae soup of person is controlled it to control the stomach.
Below being embodiment provided by the present invention, only is to further specify application of the present invention, rather than limits.
Embodiment 1
The present invention treats the Chinese medicine composition of gastropathy, and it is processed by following raw material of Chinese medicine medicine: 8 parts of Fructus Aurantiis, 16 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of the Rhizoma Pinelliaes, 15 parts of Radix Ophiopogonis, 14 parts in Rhizoma Zingiberis Recens, 30 parts of Mel.
Embodiment 2
The present invention treats the Chinese medicine composition of gastropathy, and it is processed by following raw material of Chinese medicine medicine: 8 parts of Fructus Aurantiis, 16 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of the Rhizoma Pinelliaes, 16 parts of Radix Ophiopogonis, 14 parts in Rhizoma Zingiberis Recens, 30 parts of Mel.
Embodiment 3
The present invention treats the Chinese medicine composition of gastropathy, and it is processed by following raw material of Chinese medicine medicine: 10 parts of Fructus Aurantiis, 18 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of the Rhizoma Pinelliaes, 18 parts of Radix Ophiopogonis, 16 parts in Rhizoma Zingiberis Recens, 40 parts of Mel.
Embodiment 4
The present invention treats the Chinese medicine composition of gastropathy, and it is processed by following raw material of Chinese medicine medicine: 10 parts of Fructus Aurantiis, 20 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of the Rhizoma Pinelliaes, 20 parts of Radix Ophiopogonis, 18 parts in Rhizoma Zingiberis Recens, 50 parts of Mel.
Embodiment 5
The present invention treats the Chinese medicine composition of gastropathy, and it is processed by following raw material of Chinese medicine medicine: 11 parts of Fructus Aurantiis, 19 parts of the Rhizoma Atractylodis Macrocephalaes, 14 parts of the Rhizoma Pinelliaes, 17 parts of Radix Ophiopogonis, 18 parts in Rhizoma Zingiberis Recens, 30 parts of Mel.
Embodiment 6
The present invention treats the Chinese medicine composition of gastropathy, and it is processed by following raw material of Chinese medicine medicine: 12 parts of Fructus Aurantiis, 19 parts of the Rhizoma Atractylodis Macrocephalaes, 16 parts of the Rhizoma Pinelliaes, 16 parts of Radix Ophiopogonis, 20 parts in Rhizoma Zingiberis Recens, 60 parts of Mel.
Embodiment 7
The present invention treats the Chinese medicine composition of gastropathy, and it is processed by following raw material of Chinese medicine medicine: 9 parts of Fructus Aurantiis, 19 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of the Rhizoma Pinelliaes, 19 parts of Radix Ophiopogonis, 22 parts in Rhizoma Zingiberis Recens, 60 parts of Mel.
The Chinese medicine composition that the present invention treats gastropathy can be processed capsule, tablet, pill, unguentum or oral liquid by known method and take.
As giving an example; The method for preparing of oral liquid below is described: each the tcm components crude drug that takes by weighing according to the above ratio; Fructus Aurantii, the Rhizoma Atractylodis Macrocephalae, the Rhizoma Pinelliae, Radix Ophiopogonis, Rhizoma Zingiberis Recens five kinds of Chinese medicine are put into boiling machine; The weight ratio that adds crude drug and water is the water of 1:6-8, soaks 10-30 minute, starts boiling machine; Medicinal liquid is decocted into 2/3; Filter, add Mel, bottling.
Usage: (medicine) being taken before meal usefulness, every day 2 times.
Below the clinical testing data for the present invention and Western medicine ranitidine famotidine contrasts:
Table one: the patient takes the clinical testing data contrast of the present invention and Western medicine ranitidine famotidine
? A group the present invention treatment B organizes western medicine Remarks
10 people's symptoms Flatulence, stomachache, gastric fullness Flatulence, stomachache, gastric fullness Be 10 days 1 course of treatment
First course of treatment 2 people cured in one day, and 6 people cured in 3 days, and 1 people cured in 4 days, and 1 people takes a turn for the better 4 people cured in 4 days, and 2 people cured in 7 days ?
Second course of treatment 1 people cured in 14 days 3 people take a turn for the better, 1 people's DeGrain ?
The 3rd course of treatment ? 3 people cure, and 1 people continues treatment ?
The result shows from table one, and the present invention compares with Western medicine ranitidine famotidine, and the patient thoroughly cured gastropathy, and effect is remarkable after using the present invention.
Below introduce several model cases:
Case one: Chen Siying, woman, 44 years old, peasant; The Luohe City Zhaoling District is called Lee Fu Wu village, mound town together, beginning stomach distending pain in 2009, dull pain; Anorexia, and patient's bodily form is become thin lusterless complexion; Fatigue and weakness, gastric fullness, flatulence; Indigestion, vomiting is after taking two doses of the present invention on August 10th, 2009; Cure fully, do not have repeatedly its phone: 13007680719.
Case two: Qin Ganxiu, woman, 58 years old; The retired worker, the Luohe City Zhaoling District is called Lee Fu Wu village, mound town together, December in 2009 stomachache evening on the 25th; Flatulence is full, retches, and takes the present invention after 2 hours in second day; Remission, vomiting singultus, gastric fullness; Flatulence disappears, and after the potion Chinese medicine taking, cures fully; There is not repeatedly phone: 15936632646.
Case three: Li Guoli, the man, 47 years old, the peasant, the Luohe City Zhaoling District is called Lee Fu Wu village, mound town together, in June, 2008, the diet indigestion, gastralgia, took two doses of the present invention on July 16th, 2010 after, cure fully, do not have repeatedly phone: 13673824422.
Case four: Shi Zhongliang, man, 52 years old; The peasant, the Luohe City Zhaoling District is called Lee Fu Wu village, mound town together, and 2009 begin frequent diet and vomit; Food back gastral cavilty distending pain, patient's lusterless complexion, expression is painful; Brothers' limbs are cool slightly; On October 6th, 2010, take two doses of the present invention after, cure fully; There is not repeatedly phone: 13569671950.
Case five: Li Guiying, woman, 52 years old; The peasant, fertile always township Xu Zhai people from village of Luohe City, on May 14th, 2011, flatulence was full; Pain, vomiting, singultus can not be taken food; Feed pain more very gastric qi is not following; Retch, took two doses of the present invention on May 25th, 2011 after, cure fully; There is not repeatedly phone: 13781744908.
Case six: Luo Liangyu, the woman, 23 years old, the Luohe City Zhaoling District was called Lee Fu Wu village, mound town together, gastropathy outbreak on March 20th, 2009, anorexia, take two doses of the present invention after, the flatulence pain, vomiting, the singultus symptom all disappears, and does not have repeatedly phone: 13513851362.
Case seven: Zhang Gailian, the woman, 66 years old, the peasant, the Luohe City Zhaoling District is called Lee Fu Wu village, mound town together; December in 2009 gastric fullness flatulence on the 5th, anorexia, and emaciation and sallow complexion, weak breath is unable, on January 8th, 2010; After taking two doses of the present invention, cure fully, do not have repeatedly phone: 0395-6848786.
Case eight: Shi Minying, woman, 42 years old, teacher, the mid-way primary school in Luohe City Yuanhui District Mount Taishan; On March 26th, 2011 the stomach abdominal pain, feeling of distension and oppression does not relax, with vomiting, examination in hospital is a superficial gastritis through the city; After taking two doses of the present invention, cure fully, do not have repeatedly phone: 13939592927.
Case nine: Li Qiuyu, the woman, 43 years old, the peasant, the Luohe City Zhaoling District is called Lee Fu Wu village, mound town together, on April 6th, 2010; The gastral cavilty distending pain, lack of appetite, belch, bitter taste, and complexion jaundice; Spiritlessness and weakness, take two doses of the present invention after, cure fully, do not have repeatedly phone: 15039581104.
Case ten: Li Junying, the woman, 45 years old, the peasant, the Luohe City Zhaoling District is called Lee Fu Wu village, mound town together; On May 19th, 2011 suffered from gastric fullness, flatulence, and stomach pain, vomiting is a chronic gastritis through examination in hospital sometimes; After taking two doses of the present invention, cure fully, do not have repeatedly phone: 13733958547.
What should illustrate at last is; Above embodiment is only unrestricted in order to technical scheme of the present invention to be described; Although the present invention is described in detail with reference to preferred embodiment; Those of ordinary skill in the art is to be understood that; Can make amendment or be equal to replacement technical scheme of the present invention; And not breaking away from the spirit and scope of technical scheme of the present invention, it all should be encompassed in the middle of the claim scope of the present invention.

Claims (9)

1. Chinese medicine composition of treating gastropathy, it is characterized in that: it comprises following weight portion raw material: Fructus Aurantii 9-13 part, Rhizoma Atractylodis Macrocephalae 15-22 part, Rhizoma Pinelliae 14-16 part, Radix Ophiopogonis 16-24 part, Rhizoma Zingiberis Recens 12-22 part, Mel 30-60 part.
2. the Chinese medicine composition of treatment gastropathy according to claim 1 is characterized in that: it comprises following weight portion raw material: Fructus Aurantii 8-12 part, Rhizoma Atractylodis Macrocephalae 16-20 part, Rhizoma Pinelliae 14-16 part, Radix Ophiopogonis 16-20 part, Rhizoma Zingiberis Recens 14-22 part, Mel 30-60 part.
3. the Chinese medicine composition of treatment gastropathy according to claim 1 is characterized in that: it comprises following weight portion raw material: 8 parts of Fructus Aurantiis, 16 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of the Rhizoma Pinelliaes, 15 parts of Radix Ophiopogonis, 14 parts in Rhizoma Zingiberis Recens, 30 parts of Mel.
4. the Chinese medicine composition of treatment gastropathy according to claim 1 is characterized in that: it comprises following weight portion raw material: 8 parts of Fructus Aurantiis, 16 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of the Rhizoma Pinelliaes, 16 parts of Radix Ophiopogonis, 14 parts in Rhizoma Zingiberis Recens, 30 parts of Mel.
5. the Chinese medicine composition of treatment gastropathy according to claim 1 is characterized in that: it comprises following weight portion raw material: 10 parts of Fructus Aurantiis, 18 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of the Rhizoma Pinelliaes, 18 parts of Radix Ophiopogonis, 16 parts in Rhizoma Zingiberis Recens, 40 parts of Mel.
6. the Chinese medicine composition of treatment gastropathy according to claim 1 is characterized in that: it comprises following weight portion raw material: 10 parts of Fructus Aurantiis, 20 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of the Rhizoma Pinelliaes, 20 parts of Radix Ophiopogonis, 18 parts in Rhizoma Zingiberis Recens, 50 parts of Mel.
7. the Chinese medicine composition of treatment gastropathy according to claim 1 is characterized in that: it comprises following weight portion raw material: 11 parts of Fructus Aurantiis, 19 parts of the Rhizoma Atractylodis Macrocephalaes, 14 parts of the Rhizoma Pinelliaes, 17 parts of Radix Ophiopogonis, 18 parts in Rhizoma Zingiberis Recens, 30 parts of Mel.
8. the Chinese medicine composition of treatment gastropathy according to claim 1 is characterized in that: it comprises following weight portion raw material: 12 parts of Fructus Aurantiis, 19 parts of the Rhizoma Atractylodis Macrocephalaes, 16 parts of the Rhizoma Pinelliaes, 16 parts of Radix Ophiopogonis, 20 parts in Rhizoma Zingiberis Recens, 60 parts of Mel.
9. the Chinese medicine composition of treatment gastropathy according to claim 1 is characterized in that: it comprises following weight portion raw material: 9 parts of Fructus Aurantiis, 19 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of the Rhizoma Pinelliaes, 19 parts of Radix Ophiopogonis, 22 parts in Rhizoma Zingiberis Recens, 60 parts of Mel.
CN2011102771039A 2010-11-08 2011-09-19 Traditional Chinese medicine composition used for treating gastric disease Expired - Fee Related CN102302764B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011102771039A CN102302764B (en) 2010-11-08 2011-09-19 Traditional Chinese medicine composition used for treating gastric disease

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201010533671.6 2010-11-08
CN201010533671 2010-11-08
CN2011102771039A CN102302764B (en) 2010-11-08 2011-09-19 Traditional Chinese medicine composition used for treating gastric disease

Publications (2)

Publication Number Publication Date
CN102302764A true CN102302764A (en) 2012-01-04
CN102302764B CN102302764B (en) 2013-05-15

Family

ID=45376746

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011102771039A Expired - Fee Related CN102302764B (en) 2010-11-08 2011-09-19 Traditional Chinese medicine composition used for treating gastric disease

Country Status (1)

Country Link
CN (1) CN102302764B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104491809A (en) * 2014-12-23 2015-04-08 陈晨 Traditional Chinese medicine for treating gastrointestinal complications

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101199809A (en) * 2007-12-19 2008-06-18 牟秉芳 Chinese medicine prescription oral administration for treating gastric ulcer
CN101757575A (en) * 2008-12-24 2010-06-30 天津市中宝制药有限公司 Chinese medicine composition for treating incoordination between spleen and stomach

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101199809A (en) * 2007-12-19 2008-06-18 牟秉芳 Chinese medicine prescription oral administration for treating gastric ulcer
CN101757575A (en) * 2008-12-24 2010-06-30 天津市中宝制药有限公司 Chinese medicine composition for treating incoordination between spleen and stomach

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
汪红: "张泽生教授脾胃病用药特点剖析", 《江苏中医》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104491809A (en) * 2014-12-23 2015-04-08 陈晨 Traditional Chinese medicine for treating gastrointestinal complications

Also Published As

Publication number Publication date
CN102302764B (en) 2013-05-15

Similar Documents

Publication Publication Date Title
CN102178912B (en) Chinese medicine preparation for relieving gastral cavity crymodynia symptoms of people with yang deficiency as well as preparation method and application thereof
CN102178884A (en) Chinese medicine preparation for regulating weakness of spleen and stomach of people with deficiency of vital energy, preparation method and application thereof
CN108567829A (en) A kind of Chinese medicine and preparation method thereof for treating rheumatism osteoarthropathy
CN104225441A (en) Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition
CN102698180B (en) Chinese medicine for radically treating stomach diseases
CN102166315B (en) Traditional Chinese medicine preparation for people with damp heat constitution to remove and resolve humidity, preparation method thereof and application thereof
CN104352920A (en) Digestion-helping and stomach-conditioning traditional Chinese medicinal composition
CN105396072A (en) Decoction capable of clearing heat, detoxifying, and relieving pain
CN103341150A (en) Traditional Chinese medicine preparation for treating chronic gastritis
CN1528408A (en) Kangning Stomach invigorating capsule
CN103933512B (en) Traditional Chinese medicine preparation for treating chronic gastritis
CN103330914B (en) Traditional Chinese medicine composition for treating chronic gastritis
CN104383403B (en) A kind of Chinese medicine composition treating chronic gastritis
CN102091279B (en) Traditional Chinese medicine composition for treating duodenal ulcer
CN102302764B (en) Traditional Chinese medicine composition used for treating gastric disease
CN106237252A (en) Heat-clearing and toxic substances removing pain relieving soup
CN102727786A (en) Chinese traditional medicine for treating chronic gastritis
CN102772536B (en) Chinese medicine formulae for treating hepatitis with cirrhotic ascites
CN101204565B (en) Peroral Chinese traditional medicine prescripton for superficial gastritis
CN104721745A (en) Traditional Chinese medicine composition for treating chronic pancreatitis
CN104352899A (en) Traditional Chinese medicinal preparation for treating chronic gastritis
CN107854662A (en) A kind of Chinese medicine preparation for treating cirrhotic ascites and preparation method thereof
CN108686197A (en) A kind of Chinese medicine composition that treating gastritis and its application
CN102652822A (en) Traditional Chinese medicine oral liquid used for curing coronary heart disease
CN104189315B (en) A kind of Chinese medicine for the treatment of expectorant blood stasis type globus hystericus

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130515

Termination date: 20160919

CF01 Termination of patent right due to non-payment of annual fee